Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phaseJohn Mascarenhas, Ronald Hoffman, Raajit K. Rampal et al.|Blood Advances|2020Cited by 74
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosisAndrew Dunbar, Ronald Hoffman, Dongjoo Kim et al.|Blood|2023Cited by 37
In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancyRobert L. Bowman, Ross L. Levine, Suean Daimia Fontenard et al.|Cancer Cell|2024Cited by 12
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosisAndrew Dunbar, Ronald Hoffman, Dongjoo Kim et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 6
Increased Interleukin-8 (IL8)-CXCR2 Signaling Promotes Progression of Bone Marrow Fibrosis in Myeloproliferative NeoplasmsAndrew Dunbar, Ronald Hoffman, Min Lü et al.|Blood|2020Cited by 5